U.S. Healthtech Stock News

BigBear.ai recently opened its first Middle East office at the World Trade Center Abu Dhabi, deepening its investment in the region and building on partnerships with local firms Vigilix and Easy Lease. At the same time, shareholders approved a large increase in authorized common shares and tighter bylaw rules on proxy contests, reshaping how the company can raise capital and manage future shareholder influence. We’ll now examine how the Middle East expansion and fresh capital flexibility...

If you are wondering whether FIGS is still a smart buy after its big recovery, you are not alone. This stock has attracted a lot of attention from investors trying to work out if the current price reflects its true value. Over the past week FIGS is up 2.8%. It has climbed 31.5% over the last month, 97.1% year to date, and 86.1% over the last year, a huge swing that can signal both rising optimism and a shift in how the market views its risk and growth profile. That surge has come as...

On December 5, 2025, Progressive’s board declared an annual common share dividend of US$13.50 per share and a quarterly dividend of US$0.10 per share, both payable on January 8, 2026, to shareholders of record as of January 2, 2026. Progressive also expanded its relationship with fintech Best Egg, bringing personal loan offerings into its ecosystem at a time when the insurer has recently reported very large gains in earnings per share, net premiums earned, and book value per share. We’ll now...

Ooma (OOMA) just posted Q3 2026 results with revenue of about $67.6 million and basic EPS of roughly $0.05, alongside net income excluding extra items of around $1.4 million, giving investors a fresh read on how the turnaround is holding up. The company has seen revenue move from about $65.1 million in Q3 2025 to $67.6 million in Q3 2026, while basic EPS shifted from approximately -$0.09 to $0.05 over the same window. This signals a cleaner earnings profile that puts the focus squarely on how...

If you have ever wondered whether Northrop Grumman is still good value after its long run, you are not alone. This stock tends to attract patient investors who care about quality and price. The share price sits around $550.63, roughly flat over the last week at -0.5% and down -2.2% over the past month. It is still up 17.7% year to date and 98.0% over five years, which keeps the question of future upside very much alive. Recent headlines have centered on Northrop Grumman's key role in next...

If you are wondering whether Royal Gold’s rally still has room to run or if the stock is already priced for perfection, you are in the right place to unpack what the current share price really implies. After a strong climb to around $203, the stock is up 10.0% over the last month and roughly 51.0% year to date, with an 88.8% gain over 3 years and 95.4% over 5 years that has clearly caught investors’ attention. Those gains have come as investors have leaned back into gold royalty and...

Shopify (NasdaqGS:SHOP) has been back in focus as recent investor letters spotlight its 31% year over year revenue and gross merchandise value growth, supported by new enterprise wins and ongoing investments in AI driven commerce tools. See our latest analysis for Shopify. Those growth signals have not gone unnoticed, with Shopify’s share price now at $159.89 and a strong year to date share price return of 48.69% pointing to building momentum. Its three year total shareholder return of...

Recently, RBC Capital upgraded Colgate-Palmolive to Outperform, citing the company’s large revenue base, strong pricing power, and best-in-class gross margin of 60.3% as reasons for greater confidence in its outlook. The upgrade also highlights Colgate-Palmolive’s robust free cash flow generation, which provides flexibility to both invest in growth initiatives and return capital to shareholders. We’ll now explore how RBC’s increased confidence in Colgate-Palmolive’s earnings resilience could...

VICI Properties (VICI) has quietly slipped about 16% over the past 3 months, and that drawdown is getting income focused investors asking whether this Las Vegas anchored REIT is finally offering a better entry point. See our latest analysis for VICI Properties. Zooming out, that recent 3 month share price slide comes after a choppier year in which VICI’s share price return has turned mildly negative even as management continued adding casinos and experiential assets on long leases, suggesting...

If you are wondering whether TEGNA at around $19.55 is quietly underpriced or already fairly valued, you are in the right place to unpack what the numbers are really saying. The stock has inched up 0.8% over the last week and 4.1% year to date, and while the 7.6% 1 year and 58.0% 5 year returns are solid, the slightly negative 1 month move of -1.9% hints that the market is still undecided about its next big swing. Recent headlines have focused on TEGNA's ongoing role as a major local TV...

Wondering if Roblox at around $99 a share is still a smart buy after its huge run, or if the easy money has already been made? This article will walk through what the numbers really say about its value. The stock has climbed 68.3% year to date and 76.0% over the last year, even after a recent 7.3% pullback over the past month and a 5.7% rebound in just the last week. This signals that investors are still willing to pay up for growth. Recent headlines have focused on Roblox expanding beyond...

IRADIMED (IRMD) just handed investors a year end gift by approving a special 0.50 dollar per share cash dividend that sits on top of its regular payouts and signals confidence in future cash generation. See our latest analysis for IRADIMED. The move comes after IRADIMED highlighted its growth story at recent investor conferences, and the strong backdrop shows in the numbers, with the share price up sharply this year and multi year total shareholder returns suggesting that momentum is still...

Market context and recent performance Regeneron Pharmaceuticals (REGN) has been drifting lower in the past week, even after a solid run over the past 3 months. This has prompted investors to revisit whether the recent pullback offers a reasonable entry point. See our latest analysis for Regeneron Pharmaceuticals. The recent 7 day share price pullback sits against a still impressive 90 day share price return of 24.6 percent. However, a softer 1 year total shareholder return of negative 10.5...

If you are wondering whether Hecla Mining is still worth buying after its huge run up, you are not alone. This article is going to unpack what the current price really implies about future returns. The stock has slipped about 2.1% over the last week, but it is still up 13.2% over the past month, 223.2% year to date, and 191.2% over the last year. This naturally raises questions about how much upside is left versus how much risk has crept in. Behind these big moves, investors have been...

S&P Global Indices recently announced that Hawaiian Electric Industries was added to the S&P SmallCap 600 Index as part of its latest quarterly rebalancing, reflecting the utility’s qualification under the index’s size and liquidity criteria. This mechanical inclusion, which often attracts buying from index-tracking funds, highlights how index membership can influence trading activity without altering the company’s underlying business fundamentals. We’ll now examine how Hawaiian Electric’s...

If you have ever looked at McDonald's and wondered whether a global fast food icon can still be a value play, you are exactly who this breakdown is for. The stock has quietly climbed to around $310.79, with returns of 3.3% over the last week, 3.7% over the last month, 6.2% year to date, 5.8% over 1 year, and 62.1% over 5 years, which naturally raises questions about how much upside is left. Recent headlines have focused on McDonald's ongoing menu innovation and digital initiatives, from...

Wondering if Baidu is a bargain or a value trap at today’s price? Let’s break down what the market is really pricing in and where the opportunity might lie. Baidu’s share price has climbed 4.2% over the last week and is up a hefty 49.9% year to date, even though the last 30 days have been slightly negative at -1.6%. Over the past year it is still sitting on a 38.9% gain, despite only a modest 3 year return of 4.0% and a 5 year loss of -33.2%. Recent moves have been driven by growing optimism...

Robinhood Markets (HOOD) has quietly turned into a big winner for patient investors, with the stock up around 164% over the past year as the business scales and profitability improves. See our latest analysis for Robinhood Markets. That momentum has been fueled by improving fundamentals and growing engagement on the platform, with a robust year to date share price return of 244.09% and a powerful 1-year total shareholder return of 263.25% signaling that sentiment has meaningfully shifted in...

Why Coca-Cola's Valuation Deserves a Closer Look Coca-Cola has long been viewed as a classic defensive stock, but its current share price is raising fresh questions about whether investors are paying up for safety or getting a fair deal. To figure that out, it can help to break down its value using a few different lenses rather than relying on reputation alone. On the surface, Coke still appears to be the steady compounder it has long been, with dependable cash flows and one of the strongest...

If you are wondering whether Thermo Fisher Scientific is still a smart buy at around $563 a share, or if the easy gains are already behind it, this breakdown will help you evaluate what you might really be paying for. The stock is up 7.8% year to date and 5.7% over the last year, but that climb has cooled recently, with a 2.3% dip over the past month and a 3.0% slide in the last week, suggesting that market sentiment is in flux. Investors have been reacting to a mix of headlines around...

FinVolution Group (FINV) is back in the spotlight after fresh coverage underscored its shift to a capital light consumer credit facilitator model, stronger international momentum and management’s renewed confidence in revenue growth into 2025. See our latest analysis for FinVolution Group. Despite the fresh enthusiasm, the stock’s 90 day share price return of negative 32.46% and year to date share price return of negative 23.89% show sentiment is still resetting. At the same time, the five...

Power Solutions International recently reported that its pivot toward higher-growth emission-certified power systems, especially for data centers, has driven substantial increases in 2025 net sales and net income, supported by a revised revolving credit facility and removal of prior going-concern uncertainty. This shift positions the company as a cash-generative integrator benefiting from surging on-site generation needs tied to AI and data-center expansion, creating a clearer operational...

Wondering if Vistra is still worth buying after its massive run, or if most of the upside is already baked into the price? Here is a closer look at what the current share price implies about its future. After an explosive multiyear climb of 613.3% over 3 years and 891.3% over 5 years, the stock has cooled off recently, slipping 4.5% in the last week and 13.7% over the past month, while still sitting on a 10.1% gain year to date and 17.1% over the last year. These moves are happening against...

If you are wondering whether D.R. Horton at around $149 a share is a bargain or a value trap right now, you are not alone, and this breakdown is designed to address exactly that question. The stock is up 121.2% over five years and 76.2% over three years, but more recently it is down 5.7% over the last week, up 3.2% over the last month, and only 8.5% higher year to date. This suggests the market is rethinking its risk and growth expectations. Those swings are happening against a backdrop of...